About Dr. Correa

I am a surgical oncologist specializing in pancreatic and hepatobiliary disease. My practice focuses on cancers of the pancreas, liver, and biliary system — where treatment decisions are often complex and not always straightforward.

I work within a multidisciplinary team and am closely involved in coordinating care across surgery, medical oncology, radiation oncology, radiology, and gastroenterology. Many of the patients I see have already been evaluated elsewhere or present with problems that do not have a single obvious solution.

My practice is at Mount Sinai Health System in New York City, where I operate as part of a high-volume program with access to advanced imaging, interventional endoscopy, liver-directed therapies, and clinical trials.

Camilo Correa, MD

How I Approach Decisions

Surgical oncology is as much about judgment as it is about technique.

Judgment Over Protocol

A large part of surgical oncology is not technical — it is judgment. The question is rarely “can an operation be done,” but whether it should be done, when, and under what conditions.

Honest Uncertainty

The available data is often incomplete or conflicting. Guidelines are useful, but they do not resolve every case. Decisions require weighing risk and recognizing when multiple reasonable paths exist.

Multidisciplinary by Default

No single specialist has the full picture. Every complex case benefits from review across surgery, medical oncology, radiology, gastroenterology, and radiation oncology before a decision is made.

The goal is to make decisions that are oncologically sound, technically appropriate, and aligned with what matters to the patient.

Surgical Expertise

Bile duct resection and reconstruction
Cholecystectomy with radical re-resection for gallbladder cancer
Hepatic resection (hemihepatectomy, segmentectomy)
Gastrectomy (total and subtotal)
Hepatic arterial infusion pump therapy
Abdominal and retroperitoneal sarcoma
Robotic and minimally invasive surgery

Education & Training

MD — Medical Degree
2007
Facultad de Medicina, Universidad de Antioquia
Medellín, Colombia
Postdoctoral Research Fellowship — Pancreas Surgery
2009
Harvard Medical School & Massachusetts General Hospital
Boston, MA
Clinical Research Fellowship — HPB Surgical Oncology
2013
Memorial Sloan Kettering Cancer Center
New York, NY
General Surgery Residency
2016
Indiana University School of Medicine
Indianapolis, IN
Clinical Fellow — Complex Surgical Oncology
2018
Memorial Sloan Kettering Cancer Center
New York, NY

Current Positions

Associate Professor of Surgery
Department of Surgery, Division of Surgical Oncology
Mount Sinai Health System
Associate Program Director, Complex Surgical Oncology Fellowship
Icahn School of Medicine at Mount Sinai

Board Certifications

American Board of Surgery
General Surgery
American Board of Surgery
Complex General Surgical Oncology

Selected Publications

A selection of peer-reviewed publications by disease area. View full bibliography on PubMed →

Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic Cancer.

Li J, Li TM, Geffner A, Neugarten S, Correa-Gallego C, et al. Ann Surg Oncol. 2026.

Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: An analysis of the National Cancer Database.

Kaslow SR, Hani L, Cohen SM, Wolfgang CL, Sacks GD, Berman RS, Lee AY, Correa-Gallego C. J Surg Oncol. 2023.

Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis.

Kaslow SR, Vitiello GA, Prendergast K, Hani L, Cohen SM, Wolfgang C, Berman RS, Lee AY, Correa-Gallego C. Ann Surg Oncol. 2022.

Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis.

Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, Fisher S, Viñuela EF, Kingham TP, Fong Y, DeMatteo RP, D'Angelica MI, Jarnagin WR, Allen PJ. J Am Coll Surg. 2014.

Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.

Correa-Gallego C, Do R, Lafemina J, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ. Ann Surg Oncol. 2013.

Incidental pancreatic cysts: do we really know what we are watching?

Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernández-Del Castillo C. Pancreatology. 2010.

Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver Metastases.

Li J, Waller G, Qin Y, Yu AT, Li T, Li D, Srouji R, Correa-Gallego C, et al. Ann Surg Oncol. 2026.

Stereotactic Body Radiation Therapy versus Surgical Resection for Stage I/II Hepatocellular Carcinoma.

Birgin E, Hetjens S, Tam M, Correa-Gallego C, Rahbari NN. Cancers (Basel). 2023.

Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma.

Correa-Gallego C, Maddalo D, Doussot A, Kemeny N, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Betel D, Klimstra D, Jarnagin WR, Ventura A. PLoS One. 2016.

Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.

Correa-Gallego C, Gavane S, Grewal R, Cercek A, Klimstra DS, Gewirtz AN, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N, D'Angelica MI. HPB (Oxford). 2015.

Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy.

Kingham TP, Correa-Gallego C, D'Angelica MI, Gönen M, DeMatteo RP, Fong Y, Allen PJ, Blumgart LH, Jarnagin WR. J Am Coll Surg. 2015.

Renal function after low central venous pressure-assisted liver resection: assessment of 2,116 cases.

Correa-Gallego C, Berman A, Denis SC, Langdon-Embry L, O'Connor D, Arslan-Carlon V, Kingham TP, D'Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR, Melendez J, Fischer M. HPB (Oxford). 2015.

Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.

D'Angelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N. Ann Surg. 2015.

Minimally Invasive Gastrectomy.

Waller GC, Khan TM, Correa-Gallego C. Surg Clin North Am. 2025.

Time to Curative-Intent Surgery in Gastric Cancer Shows a Bimodal Relationship with Overall Survival.

Kaslow SR, He Y, Sacks GD, Berman RS, Lee AY, Correa-Gallego C. J Gastrointest Surg. 2023.

Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: A US safety net collaborative analysis.

Leder Macek AJ, Wang A, Turgeon MK, Lee RM, Russell MC, Porembka MR, Alterio R, Ju M, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Berman RS, Correa-Gallego C, Lee AY. J Surg Oncol. 2022.

Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer.

Kaslow SR, Ma Z, Hani L, Prendergast K, Vitiello G, Lee AY, Berman RS, Goldberg JD, Correa-Gallego C. J Surg Oncol. 2022.

Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients With Gastric Cancer.

Vitiello GA, Hani L, Wang A, Porembka MR, Alterio R, Ju M, Turgeon MK, Lee RM, Russell MC, Kronenfeld J, Goel N, Datta J, Maker AV, Fernandez M, Richter H, Correa-Gallego C, Berman RS, Lee AY. J Surg Res. 2021.

Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival: Results of a Blinded, Prospective Trial.

Khajoueinejad N, Sarfaty E, Yu AT, Buseck A, Troob S, Imtiaz S, Mohammad A, Cha DE, Pletcher E, Gleeson E, Macfie R, Carr J, Hiotis SP, Golas B, Correa-Gallego C, et al. Ann Surg Oncol. 2024.

Survival in ampullary cancer: potential role of different KRAS mutations.

Valsangkar NP, Ingkakul T, Correa-Gallego C, Mino-Kenudson M, Masia R, Lillemoe KD, Fernández-del Castillo C, Warshaw AL, Liss AS, Thayer SP. Surgery. 2015.

View the complete list of publications on PubMed.

What This Site Is For

This site is an extension of the clinical approach described above. It is intended to make complex problems more understandable without oversimplifying them.

Some content is written for patients and families navigating a new diagnosis. Other sections are aimed at referring providers looking for clinical criteria and referral pathways. All of it is meant to clarify how decisions are actually made in practice — including where uncertainty remains.

This is not a substitute for medical advice. It is a way to make clinical discussions more informed and more productive.

Ready to Schedule a Consultation?

Contact the office to request an appointment or to discuss a referral.